Alimta and haemoglobin decreased Patient Reports February 12, 2012

Alimta Side Effects Report #5012931-2
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2006. Female patient, weighting 148.4 lb, was diagnosed with squamous cell carcinoma of the cervix and was treated with Alimta. After drug was administered, patient experienced the following side effects: abasia, asthenia, blood pressure increased, haemoglobin decreased, heart rate increased, localised oedema, lymphoedema, oedema peripheral, platelet count decreased. Alimta dosage: 978 MG. Patient was hospitalized. Patient died on 05/21/2006.

Alimta Side Effects Report #4692895-1
Alimta side effect was reported by a Physician from on May 26, 2005. Male patient, 72 years of age, was diagnosed with pleural mesothelioma and was treated with Alimta. After drug was administered, patient experienced the following side effects: aplasia, diarrhoea, dyspnoea, haemoglobin decreased, leukopenia, neutropenia, pain , platelet count decreased, subileus. Alimta dosage: 940 MG OTHER. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 11/26/2004.

Alimta Side Effects Report #4642411-5
Alimta side effect was reported by a Physician from on Apr 06, 2005. Male patient, 69 years of age, was diagnosed with pleural mesothelioma and was treated with Alimta. After drug was administered, patient experienced the following side effects: aortic atherosclerosis, arrhythmia , atrial fibrillation , bundle branch block left, cardiovascular disorder, dyspnoea, haemoglobin decreased, hepatic steatosis, hypertension. Alimta dosage: 500 MG/M2. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4746433-5
Alimta side effect was reported by a Physician from AUSTRALIA on July 26, 2005. Male patient, 57 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood fibrinogen increased, eosinophil count decreased, haematocrit decreased, haemoglobin decreased, idiopathic thrombocytopenic purpura, neutrophil count increased, red blood cell count decreased, red cell distribution width increased, white blood cell count increased. Alimta dosage: 840 MG OTHER. During the same period patient was treated with CISPLATIN, ASTRIX, NOTEN, LIPITOR, IMDUR, FOLIC ACID, DEXAMETHASONE, VITAMIN B. Patient recovered.


Alimta Side Effects Report #5117615-8
Alimta side effect was reported by a Physician from AUSTRALIA on Sept 06, 2006. Female patient, 82 years of age, was diagnosed with non-small cell lung cancer stage iiib and was treated with Alimta. After drug was administered, patient experienced the following side effects: diarrhoea, escherichia urinary tract infection, haemoglobin decreased, nausea , neutrophil count decreased, platelet count decreased, sepsis , white blood cell count decreased. Alimta dosage: 690 MG, OTHER,. During the same period patient was treated with CYANOCOBALAMIN, FOLIC ACID. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4724031-7
Alimta side effect was reported by a Physician from UNITED KINGDOM on July 01, 2005. Male patient, 72 years of age, weighting 167.6 lb, was diagnosed with non-small cell lung cancer recurrent and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood potassium decreased, confusional state, decreased appetite, disease progression, fatigue, haemoglobin decreased, immunosuppression. Alimta dosage: 1700 MG/1 OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, ISOSORIDE MONONITRATE, ATORVASTATIN CALCIUM, DOCUSATE, METOCLOPRAMIDE, FLUCONAZOLE, SENNA. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5928242-4
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 14, 2008. Male patient, 86 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: haemoglobin decreased, mastication disorder, mouth ulceration. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B. Patient died on 09/30/2008.

Alimta Side Effects Report #4832350-9
Alimta side effect was reported by a Physician from UNITED STATES on Nov 07, 2005. Female patient, 78 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count increased. Alimta dosage: 500 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS, CISPLATIN. Patient was hospitalized. Patient died on 08/30/2005.

Alimta Side Effects Report #4803250-5
Alimta side effect was reported by a Physician from UNITED STATES on Sept 27, 2005. Male patient, 77 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased. Alimta dosage: 500 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEOID NOS. Patient recovered.


Alimta Side Effects Report #4832351-0
Alimta side effect was reported by a Physician from UNITED STATES on Nov 07, 2005. Male patient, 77 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count decreased, small intestinal haemorrhage. Alimta dosage: 500 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4803252-9
Alimta side effect was reported by a Physician from UNITED STATES on Sept 27, 2005. Male patient, 58 years of age, weighting 147.7 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased. Alimta dosage: 600 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS, CISPLATIN. Patient died.

Alimta Side Effects Report #4832726-X
Alimta side effect was reported by a Physician from UNITED STATES on Nov 07, 2005. Male patient, 58 years of age, weighting 147.7 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, platelet count decreased. Alimta dosage: 600 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS, CISPLATIN. Patient was hospitalized. Patient died on 07/03/2005.

Alimta Side Effects Report #4684821-6
Alimta side effect was reported by a Health Professional from on Apr 05, 2005. Female patient, 77 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased. Alimta dosage: 700 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS, ZOMETA, FUROSEMIDE, RELAFEN. Patient recovered.

Alimta Side Effects Report #4662784-7
Alimta side effect was reported by a Physician from on Apr 27, 2005. Male patient, 56 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, tumour haemorrhage, white blood cell count decreased. Alimta dosage: 500 MG/M2. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized. Patient died on 04/01/2005.


Alimta Side Effects Report #5066152-8
Alimta side effect was reported by a Physician from AUSTRIA on July 09, 2006. Male patient, 47 years of age, weighting 169.8 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, chest discomfort, haemoglobin decreased, supraventricular tachycardia, white blood cell count increased. Alimta dosage: unknown. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5485617-8
Alimta side effect was reported by a Physician from GERMANY on Oct 02, 2007. Male patient was diagnosed with non-small cell lung cancer, pain  and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, c-reactive protein increased, dyspnoea, haemoglobin decreased, lymphocyte count decreased, malignant neoplasm progression, red blood cell count decreased, rib fracture. Alimta dosage: unknown. During the same period patient was treated with DURAGESIC, NOVALGIN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5486391-1
Alimta side effect was reported by a Physician from GERMANY on Oct 02, 2007. Male patient was diagnosed with non-small cell lung cancer, pain  and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, c-reactive protein increased, dyspnoea, haemoglobin decreased, lymphocyte count decreased, malignant neoplasm progression, red blood cell count decreased, rib fracture. Alimta dosage: unknown. During the same period patient was treated with DURAGESIC, NOVALGIN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4642422-X
Alimta side effect was reported by a Physician from on Apr 05, 2005. Male patient, 58 years of age, was diagnosed with metastatic bronchial carcinoma and was treated with Alimta. After drug was administered, patient experienced the following side effects: haemoglobin decreased, metastatic bronchial carcinoma, neoplasm progression, pancytopenia. Alimta dosage: 500 MG/M2. During the same period patient was treated with DUROGESIC, PANTOPRAZOLE, THROMBO ASS, NOVALGIN ), PASPERTIN, CODILOL, FOLIC ACID, LAEVOLAC. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5523240-7
Alimta side effect was reported by a Health Professional from UNITED STATES on Nov 16, 2007. Female patient, weighting 135.0 lb, was diagnosed with metastasis, neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, pulmonary embolism , vaginal haemorrhage. Alimta dosage: 500 MG/M2 D 1, 8 Q 21 D IV. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.


Alimta Side Effects Report #5104662-5
Alimta side effect was reported by a Health Professional from SOUTH AFRICA on Aug 21, 2006. Male patient, 77 years of age, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: beta haemolytic streptococcal infection, blood creatinine increased, blood urine present, c-reactive protein increased, diarrhoea, febrile neutropenia, haemoglobin decreased, treatment noncompliance. Alimta dosage: 1000 MG, INTRAVENOUS. During the same period patient was treated with CISPLATIN, FOLIC ACID, CYANOCOBALAMIN. Patient was hospitalized. Patient died on 07/30/2006.

Alimta Side Effects Report #4742576-0
Alimta side effect was reported by a Physician from UNITED STATES on July 26, 2005. Male patient, 62 years of age, weighting 196.2 lb, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood sodium decreased, disease progression, dyspnoea, haematocrit decreased, haemoglobin decreased, ototoxicity, pleural effusion. Alimta dosage: 400 MG WEEK. During the same period patient was treated with GEMZAR, CISPLATIN, VITAMIN B, FOLIC ACID, PRILOSEC, VICODIN, TESSALON, FUROSEMIDE. Patient was hospitalized. Patient died on 05/23/2005.

Alimta Side Effects Report #4686982-1
Alimta side effect was reported by a Physician from on May 25, 2005. Male patient, 59 years of age, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, haemoglobin decreased, leukopenia, melaena, mucous membrane disorder, platelet count decreased, refusal of treatment by patient. Alimta dosage: 1000 MG/1 OTHER. During the same period patient was treated with CARBOPLATIN, OMEPRAZOLE, FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient died on 05/12/2005.

Alimta Side Effects Report #4625800-4
Alimta side effect was reported by a Physician from on Mar 15, 2005. Male patient, 48 years of age, weighting 187.4 lb, was diagnosed with mesothelioma  and was treated with Alimta. After drug was administered, patient experienced the following side effects: haemoglobin decreased, mental status changes, nausea , neutropenia, neutrophil count decreased, paranoia, somnolence, speech disorder. Alimta dosage: 1000 MG/1 OTHER. During the same period patient was treated with CISPLATIN, PAROXETINE, ORAMORPH, MORPHINE SULPHATE, MOVICOL, DIAZEPAM, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5848529-3
Alimta side effect was reported by a Physician from CANADA on Aug 06, 2008. Male patient was diagnosed with mesothelioma , iron deficiency anaemia and was treated with Alimta. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count increased. Alimta dosage: 975 MG Q 3 WKS, 39ML IN NS 100. During the same period patient was treated with CISPLATIN, CHLORIDE, FOLIC ACID, VITAMIN B, IRON SULPHATETHIAMIN COMPOUND. Patient recovered.


Alimta Side Effects Report #4746420-7
Alimta side effect was reported by a Physician from BRAZIL on Aug 01, 2005. Male patient, 57 years of age, was diagnosed with malignant neoplasm progression, pancreatic carcinoma and was treated with Alimta. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, blood ph decreased, blood pressure decreased, blood sodium decreased, dialysis , disorientation, haematocrit decreased, haemoglobin decreased, leukopenia. Alimta dosage: 750 MG OTHER. During the same period patient was treated with VITAMIN B, FOLIC ACID, DEXAMETHASONE, MORPHINE, GABAPENTIN, GATIFLOXACIN. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #4655723-6
Alimta side effect was reported by a Physician from on Apr 15, 2005. Male patient, 40 years of age, weighting 92.59 lb, was diagnosed with lung neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: cyanosis, dehydration, diarrhoea, haemoglobin decreased, hypovolaemic shock, lung infiltration, neutropenia, platelet count decreased, pneumonia . Alimta dosage: 500 MG/M2. During the same period patient was treated with CISPLATIN, FOLIC ACID, AMIODARONE, ONDANSETRON, DEXAMETHASONE. Patient was hospitalized. Patient died on 02/17/2005.

Alimta Side Effects Report #4803277-3
Alimta side effect was reported by a Physician from UNITED STATES on Sept 27, 2005. Female patient, 78 years of age, weighting 149.9 lb, was diagnosed with lung cancer metastatic, non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased. Alimta dosage: 500 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS, CISPLATIN. Patient died.

Alimta Side Effects Report #5779547-1
Alimta side effect was reported by a Health Professional from FRANCE on May 26, 2008. Male patient, 54 years of age, was diagnosed with lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood culture positive, eczema , febrile bone marrow aplasia, haemoglobin decreased, mucosal inflammation, neutropenia, skin toxicity, staphylococcal infection , thrombocytopenia. Alimta dosage: 975 MG EVERY FOUR WEEKS, INTRAVENOUS. During the same period patient was treated with FOLIC ACID, VITAMIN B12, DEXAMETHASONE, ZOMETA, ZOFRAN, DURAGESIC. Patient died on 02/24/2008.

Alimta Side Effects Report #4654901-X
Alimta side effect was reported by a Physician from on Apr 22, 2005. Male patient, 47 years of age, weighting 90.39 lb, was diagnosed with gastric cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood albumin decreased, blood urea increased, delirium, depressed level of consciousness, depression , haematocrit decreased, haemoglobin decreased, hepatic encephalopathy. Alimta dosage: 1184 MG/M2/1 OTHER. During the same period patient was treated with CISPLATIN, VITAMIN B, STRESS, MEDROXYPROGESTERONE. Patient was hospitalized. Patient died on 04/20/2005.


Alimta Side Effects Report #4673887-5
Alimta side effect was reported by a Physician from on May 05, 2005. Male patient, 47 years of age, weighting 90.39 lb, was diagnosed with gastric cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: abnormal behaviour, activated partial thromboplastin time prolonged, blood albumin decreased, blood urea increased, delirium, depression , haematocrit decreased, haemoglobin decreased, hepatic encephalopathy. Alimta dosage: 1184 MG/M2/1 OTHER. During the same period patient was treated with CISPLATIN, VITAMIN B, STRESS, MEDROXYPROGESTERONE. Patient was hospitalized. Patient died on 04/20/2005.

Alimta Side Effects Report #4821858-8
Alimta side effect was reported by a Physician from PERU on Oct 13, 2005. Female patient, 52 years of age, weighting 200.6 lb, was diagnosed with breast cancer  and was treated with Alimta. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, hepatotoxicity, leukopenia, skin hyperpigmentation, thermal burn, thrombocytopenia. Alimta dosage: 925 MG. During the same period patient was treated with DOXORUBICIN, ENALAPRIL, NIFEDIPINE, HYDROCHLOROTHIAZIDE, METOCLOPRAMIDE, FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Alimta Side Effects Report #5496455-4
Alimta side effect was reported by a Physician from CANADA on Oct 15, 2007. Female patient, 63 years of age, was treated with Alimta. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count increased, platelet count decreased, white blood cell count increased. Alimta dosage: unknown. Patient recovered.

Alimta Side Effects Report #5191518-5
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2006. Female patient, weighting 187.4 lb, was treated with Alimta. After drug was administered, patient experienced the following side effects: atelectasis, blood pressure diastolic decreased, convulsion, diarrhoea, haematocrit decreased, haemoglobin decreased, lobar pneumonia, lymphadenopathy, necrosis. Alimta dosage: 865 MG. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 11/23/2006.

Alimta Side Effects Report #5819551-8
Alimta side effect was reported by a Physician from CANADA on July 16, 2008. Male patient was treated with Alimta. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, platelet count increased. Alimta dosage: 975 MG, 39ML IN NS 100. During the same period patient was treated with CISPLATIN, CHLORIDE. Patient recovered.